Thyroid stimulating antibodies are highly prevalent in Hashimoto's thyroiditis and associated orbitopathy

Journal of Clinical Endocrinology and Metabolism

Volumn 101, Issue 5, 2016, Pages 1998-2004

  Kahaly, George J ^a   Diana, Tanja ^a   Glang, Jennifer ^a   Kanitz, Michael ^a   Pitz, Susanne ^a   König, Jochem ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYCLIC AMP; LUCIFERASE; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY; THYROTROPIN RECEPTOR STIMULATING ANTIBODY; UNCLASSIFIED DRUG; THYROTROPIN-BINDING INHIBITORY IMMUNOGLOBULIN;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOCRINE OPHTHALMOPATHY; FEMALE; HASHIMOTO DISEASE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOLECULAR PATHOLOGY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SMOKING; YOUNG ADULT; ADOLESCENT; ANIMAL; BLOOD; CHO CELL LINE; CRICETULUS; HAMSTER; IMMUNOLOGY;

ADOLESCENT; ADULT; ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; FEMALE; GRAVES OPHTHALMOPATHY; HASHIMOTO DISEASE; HUMANS; IMMUNOGLOBULINS, THYROID-STIMULATING; MALE; MIDDLE AGED; RECEPTORS, THYROTROPIN; YOUNG ADULT;

EID: 84969849818     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2016-1220     Document Type: Article

References (30)

1. Ajjan RA, Weetman AP. The pathogenesis of Hashimoto's thyroiditis: further developments in our understanding. Horm Metab Res. 2015;47:702-710.
2. Brown RS. Autoimmune thyroiditis in childhood. J Clin Res Pediatr Endocrinol. 2013;5 Suppl 1:45-49.
3. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87:489-499.
4. Tamai H, Nakagawa T, Ohsako N, et al. Changes in thyroid functions in patients with euthyroid Graves' disease. J Clin Endocrinol Metab. 1980;50:108-112.
5. Kraiem Z, Baron E, Kahana L, Sadeh O, Sheinfeld M. Changes in stimulating and blocking TSH receptor antibodies in a patient under going three cycles of transition from hypo to hyper-thyroidism and back to hypothyroidism. Clin Endocrinol (Oxf). 1992;36:211-214.
6. Adams DD. The presence of an abnormal thyroid-stimulating hormone in the serum of some thyrotoxic patients. J Clin Endocrinol Metab. 1958;18:699-712.
7. Smith BR, Hall R. Thyroid-stimulating immunoglobulins in Graves' disease. Lancet. 1974;2:427-431.
8. Konishi J, Iida Y, Kasagi K, et al. Primary myxedema with thyrotrophin-binding inhibitor immunoglobulins. Clinical and laboratory findings in 15 patients. Ann Intern Med. 1985;103:26-31.
9. Kraiem Z, Lahat N, Glaser B, Baron E, Sadeh O, Sheinfeld M. Thyrotrophin receptor blocking antibodies: incidence, characterization and in-vitro synthesis. Clin Endocrinol (Oxf). 1987;27:409-421.
10. Nagayama Y, Rapoport B. The thyrotropin receptor 25 years after its discovery: new insight after its molecular cloning. Mol Endocrinol. 1992;6:145-156.
11. Takasu N, Yamada T, Sato A, et al. Graves' disease following hypothyroidism due to Hashimoto's disease: studies of eight cases. Clin Endocrinol (Oxf). 1990;33:687-698.
12. McLachlan SM, Rapoport B. Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa. Thyroid. 2013;23:14-24.
13. Feingold SB, Smith J, Houtz J, Popovsky E, Brown RS. Prevalence and functional significance of thyrotropin receptor blocking antibodies in children and adolescents with chronic lymphocytic thyroiditis. J Clin Endocrinol Metab. 2009;94:4742-4748.
14. Abe E, Marians RC, Yu W, et al. TSH is a negative regulator of skeletal remodeling. Cell. 2003;115:151-162.
15. Haraguchi K, Shimura H, Kawaguchi A, Ikeda M, Endo T, Onaya T. Effects of thyrotropin on the proliferation and differentiation of cultured rat preadipocytes. Thyroid. 1999;9:613-619.
16. Lytton SD, Ponto KA, Kanitz M, Matheis N, Kohn LD, Kahaly GJ. A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy. J Clin Endocrinol Metab. 2010;95:2123-2131.
17. Ponto KA, Hommel G, Pitz S, Elflein H, Pfeiffer N, Kahaly GJ. Quality of life in a german graves orbitopathy population. Am J Ophthalmol. 2011;152:483-490 e481.
18. Diana T, Brown RS, Bossowski A, et al. Clinical relevance of thyroid-stimulating autoantibodies in pediatric graves' disease-a multicenter study. J Clin Endocrinol Metab. 2014;99:1648-1655.
19. Dickinson AJ. Clinical manifestation. In: Wiersinga WM, Kahaly GJ, eds. Graves' Orbitopathy-A Multidisciplinary Approach - Questions and Answers. 2nd ed. Basel, Switzerland: Karger; 2010:1-25.
20. Lytton SD, Li Y, Olivo PD, Kohn LD, Kahaly GJ. Novel chimeric thyroid-stimulating hormone-receptor bioassay for thyroid-stimulating immunoglobulins. Clin Exp Immunol. 2010;162:438-446.
21. Li Y, Kim J, Diana T, Klasen R, Olivo PD, Kahaly GJ. A novel bioassay for anti-thyrotrophin receptor autoantibodies detects both thyroid-blocking and stimulating activity. Clin Exp Immunol. 2013; 173:390-397.
22. Diana T, Li Y, Olivo PD, Lackner KJ, Kim H, Kanitz M, Kahaly GJ. Analytical performance and validation of a bioassay for thyroid-blocking autoantibodies. Thyroid. In press.
23. Verma R, Gupta M, Mehta VK. Thyroid associated orbitopathy. BMJ Case Rep. 2013;2013.
24. Grzesiuk W, Szydlarska D, Pragacz A, Bar-Andziak E. Thyroid-associated orbitopathy in patients with Hashimoto's thyroiditis: a case report. Pol Arch Med Wewn. 2008;118:318-321.
25. Yoshihara A, Yoshimura Noh J, Nakachi A, et al. Severe thyroid-associated orbitopathy in Hashimoto's thyroiditis. Report of 2 cases. Endocr J. 2011;58:343-348.
26. Rieu M, Richard A, Rosilio M, et al. Effects of thyroid status on thyroid autoimmunity expression in euthyroid and hypothyroid patients with Hashimoto's thyroiditis. Clin Endocrinol (Oxf). 1994; 40:529-535.
27. Rieu M, Portos C, Lissak B, et al. Relationship of antibodies to thyrotropin receptors and to thyroid ultrasonographic volume in euthyroid and hypothyroid patients with autoimmune thyroiditis. J Clin Endocrinol Metab. 1996;81:641-645.
28. Leschik JJ, Diana T, Olivo PD, et al. Analytical performance and clinical utility of a bioassay for thyroid-stimulating immunoglobulins. Am J Clin Pathol. 2013;139:192-200.
29. Ponto KA, Schuppan D, Zwiener I, et al. Thyroid-associated orbitopathy is linked to gastrointestinal autoimmunity. Clin Exp Immunol. 2014;178:57-64.
30. Ponto KA, Binder H, Diana T, et al. Prevalence, phenotype, and psychosocial well-being in euthyroid/hypothyroid thyroid-associated orbitopathy. Thyroid. 2015;25:942-948.